Peptide conjugates of GLP-1 receptor agonists and gastrin and their use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9649362
APP PUB NO 20160184400A1
SERIAL NO

14735738

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates, inter alia, to certain peptide conjugates, and to the use of the conjugates in the treatment of a variety of diseases or disorders, including diabetes (type 1 and/or type 2) and diabetes-related diseases or disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZEALAND PHARMA A/S2860 SØBORG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Østerlund, Torben Lund, SE 10 130
Brorson, Marianne Søborg, DK 3 59
Fosgerau, Keld Rødovre, DK 13 258
Martensson, Ulrika Lund, SE 2 29
Neerup, Trine Skovlund Ryge Frederikssund, DK 7 181
Rolsted, Kamilla Slagelse, DK 3 59
Tolborg, Jakob Lind Herlev, DK 22 424

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00